Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

Recursion Pharmaceuticals is trying to prove that AI’s next big winner can also come from biotech, and not just from the tech ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Stanford report reveals why Utah’s flagship university is a top destination for entrepreneurs.

Robots and AI are running experiments around the clock, from battery chemistry to cancer therapies. But can they be trusted ...

On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...

The story the market has been telling itself about artificial intelligence and drug discovery is, at its core, ...

Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...

AbCellera has an AI-driven antibody discovery platform, $650M liquidity, and an upcoming Phase 2 catalyst. Click here to read ...

How I turned a $20 piece of e-waste into a lightning-fast local DNS server ...